Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Long term safety of nine systemic medications for psoriasis: A cohort study using the Biobadaderm Registry

Journal of the American Academy of Dermatology | Mar 26, 2020 Clinical Pharmacology

Fungaemia due to rare yeasts in a tertiary care university centre within 18 years

Mycoses | Mar 26, 2020 Clinical Pharmacology

Factors associated with short-term relapse in patients with pemphigus who receive rituximab as first-line therapy: A post hoc analysis of a randomized clinical trial

JAMA | Mar 24, 2020 Clinical Pharmacology

Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study

Journal of the American Academy of Dermatology | Mar 23, 2020 Clinical Pharmacology

Association of afamelanotide with improved outcomes in patients with erythropoietic protoporphyria in clinical practice

JAMA | Mar 22, 2020 Clinical Pharmacology

Oral erythromycin in pityriasis lichenoides chronica and pityriasis lichenoides et varioliformis acuta

Dermatologic Therapy | Mar 21, 2020 Clinical Pharmacology

Comparative study of the efficacy and safety of secukinumab vs ixekizumab in moderate‐to‐severe psoriasis after one‐year of treatment: Real‐world practice

Dermatologic Therapy | Mar 21, 2020 Clinical Pharmacology

Efficacy of guselkumab in a subpopulation with pustulotic arthro‐osteitis through week 52: An exploratory analysis of a phase 3, randomized, double‐blind, placebo‐controlled study in Japanese patients with palmoplantar pustulosis

Journal of the European Academy of Dermatology and Venereology | Mar 20, 2020 Clinical Pharmacology

Drug survival, discontinuation rates, and safety profile of secukinumab in real‐world patients: A 152‐week, multicenter, retrospective study

International Journal of Dermatology | Mar 20, 2020 Clinical Pharmacology

Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: a phase ii, randomized, controlled, double-blinded trial

Journal of the American Academy of Dermatology | Mar 19, 2020 Clinical Pharmacology

« Prev 1 … 34 35 36 37 38 … 92 Next »

Long term safety of nine systemic medications for psoriasis: A cohort study using the Biobadaderm Registry

Fungaemia due to rare yeasts in a tertiary care university centre within 18 years

Factors associated with short-term relapse in patients with pemphigus who receive rituximab as first-line therapy: A post hoc analysis of a randomized clinical trial

Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study

Association of afamelanotide with improved outcomes in patients with erythropoietic protoporphyria in clinical practice

Oral erythromycin in pityriasis lichenoides chronica and pityriasis lichenoides et varioliformis acuta

Comparative study of the efficacy and safety of secukinumab vs ixekizumab in moderate‐to‐severe psoriasis after one‐year of treatment: Real‐world practice

Efficacy of guselkumab in a subpopulation with pustulotic arthro‐osteitis through week 52: An exploratory analysis of a phase 3, randomized, double‐blind, placebo‐controlled study in Japanese patients with palmoplantar pustulosis

Drug survival, discontinuation rates, and safety profile of secukinumab in real‐world patients: A 152‐week, multicenter, retrospective study

Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: a phase ii, randomized, controlled, double-blinded trial

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

MD Clip on Pulmonary Hypertension Symptoms and Management with Dr Waseem

New research aims to transform treatments of aggressive blood cancer

Long term safety of nine systemic medications for psoriasis: A cohort study using the Biobadaderm Registry

Fungaemia due to rare yeasts in a tertiary care university centre within 18 years

Factors associated with short-term relapse in patients with pemphigus who receive rituximab as first-line therapy: A post hoc analysis of a randomized clinical trial

Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study

Association of afamelanotide with improved outcomes in patients with erythropoietic protoporphyria in clinical practice

Oral erythromycin in pityriasis lichenoides chronica and pityriasis lichenoides et varioliformis acuta

Comparative study of the efficacy and safety of secukinumab vs ixekizumab in moderate‐to‐severe psoriasis after one‐year of treatment: Real‐world practice

Efficacy of guselkumab in a subpopulation with pustulotic arthro‐osteitis through week 52: An exploratory analysis of a phase 3, randomized, double‐blind, placebo‐controlled study in Japanese patients with palmoplantar pustulosis

Drug survival, discontinuation rates, and safety profile of secukinumab in real‐world patients: A 152‐week, multicenter, retrospective study

Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: a phase ii, randomized, controlled, double-blinded trial

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

MD Clip on Pulmonary Hypertension Symptoms and Management with Dr Waseem

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic